A comparative observational study on the effect of two different doses of fentanyl on the effect site concentration of propofol during induction of anesthesia using clinical assessment score and bispectral index

一项比较观察性研究,旨在探讨两种不同剂量芬太尼对麻醉诱导期间丙泊酚效应部位浓度的影响,研究采用临床评估评分和双频指数进行评估。

阅读:1

Abstract

BACKGROUND AND AIMS: Opioids are known to reduce the propofol dose required to blunt movement and hemodynamic responses to noxious stimuli. However, the optimal propofol dosage for smooth induction remains unclear, particularly in the Indian population where pharmacokinetic data is limited. This study aims to evaluate the effect site concentration of propofol in conjunction with varying fentanyl doses, with relation to loss of consciousness and bispectral index (BIS) values during anesthesia induction using target-controlled infusion (TCI). MATERIAL AND METHODS: Sixty patients aged 20-50 years, with American Society of Anesthesiologists physical status I and II, scheduled for elective surgeries under general anesthesia were included. Anesthesia induction was performed using a TCI pump with propofol based on the Schnider model, starting at 1.5 µg/ml and increasing at 0.5 µg/ml until loss of verbal response, followed by 0.2 µg/ml till the final clinical endpoint was reached. Patients received either 1 or 2 µg/kg fentanyl or no fentanyl. Endpoints were assessed using the BIS monitor and Modified Observer Assessment of Alertness/Sedation Scale score. RESULTS: Hemodynamic parameters were stable across groups. The effect site concentration of propofol for loss of response to noxious stimuli was significantly lower in the fentanyl groups (fentanyl 1 µg/kg- 2.90 ± 0.1947 µg/ml, fentanyl 2 µg/kg- 2.445 ± 0.23 µg/ml) compared to the propofol alone group (4.205 ± 0.909 µg/ml) (P = 0.0001). Similar results were observed for loss of response to verbal commands. The effect site concentration at BIS 60 corresponded to loss of response to noxious stimuli. CONCLUSIONS: Propofol effect site concentrations were significantly higher without fentanyl. The findings contribute valuable data for refining pharmacokinetic models tailored to individual patient needs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。